Seroprevalence, correlates and trends of Helicobacter pylori infection in the Israeli population

被引:26
作者
Muhsen, K. [1 ]
Cohen, D. [1 ,2 ]
Spungin-Bialik, A. [1 ]
Shohat, T. [1 ,3 ]
机构
[1] Tel Aviv Univ, Sackler Fac Med, Sch Publ Hlth, Dept Epidemiol & Prevent Med, IL-69978 Tel Aviv, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Stanley Steyer Inst Canc Epidemiol & Res, IL-69978 Tel Aviv, Israel
[3] Minist Hlth, Israel Ctr Dis Control, Tel Hashomer, Israel
关键词
ELISA; epidemiology; Helicobacter pylori; serology; ASYMPTOMATIC SUBJECTS; EARLY-CHILDHOOD; ARAB CHILDREN; RISK-FACTORS; PREVALENCE; ACQUISITION; COUNTRIES; DISEASES; AGE; TRANSMISSION;
D O I
10.1017/S0950268811002081
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
We examined the prevalence, correlates and trends of H. pylori infection in Israel using residual sera obtained in 2007-2008 from 1466 Jewish subjects aged 0-77 years and 897 Arabs aged 0-19 years, and in 2000-2001 from 627 Jewish and 575 Arab subjects aged 0-19 years. H. pylori IgG antibodies were measured by ELISA. The age-adjusted H. pylori seroprevalence was 45.2% in Jewish participants. Seropositivity increased with age, reaching 60% at age >= 50 years and ranged from 24.3% in subjects originating from North America/Western Europe/Australia, to 63.2% in those from Asia/Africa/South America. Among Arabs, H. pylori seroprevalence was 42.1% and reached 65% in adolescents. There was no significant change in seroprevalence between 2000-2001 and 2007-2008. High prevalence of H. pylori was found in Arabs, and in Jews originating from countries of high H. pylori endemicity. These findings are characteristic of countries of diverse ethnic structure and recent immigration.
引用
收藏
页码:1207 / 1214
页数:8
相关论文
共 40 条
  • [1] Abramson Joseph H, 2004, Epidemiol Perspect Innov, V1, P6, DOI 10.1186/1742-5573-1-6
  • [2] Prevalence of Helicobacter pylori infection in asymptomatic subjects in Libya
    Bakka, AS
    Salih, BA
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2002, 43 (04) : 265 - 268
  • [3] THE COHORT EFFECT AND HELICOBACTER-PYLORI
    BANATVALA, N
    MAYO, K
    MEGRAUD, F
    JENNINGS, R
    DEEKS, JJ
    FELDMAN, RA
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (01) : 219 - 221
  • [4] Bani-Hani Kamal E, 2006, Chin J Dig Dis, V7, P55, DOI 10.1111/j.1443-9573.2006.00245.x
  • [5] Antibiotics taken for other illnesses and spontaneous clearance of Helicobacter pylori infection in children
    Broussard, Cheryl S.
    Goodman, Karen J.
    Phillips, Carl V.
    Smith, Mary Ann
    Fischbach, Lori A.
    Day, R. Sue
    Aragaki, Corinne C.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 (08) : 722 - 729
  • [6] *CENTR BUR STAT, 2004, CHAR CLASS LOC AUTH
  • [7] Helicobacter pylori in Health and Disease
    Cover, Timothy L.
    Blaser, Martin J.
    [J]. GASTROENTEROLOGY, 2009, 136 (06) : 1863 - 1873
  • [8] Migrant communities constitute a possible target population for primary prevention of Helicobacter pylori-related complications in low incidence countries
    De Vries, Annemarie C.
    Van Driel, Harold F.
    Richardus, Jan H.
    Ouwendijk, Martine
    Van Vuuren, Adriana J.
    De Man, Rob A.
    Kuipers, Ernst J.
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2008, 43 (04) : 403 - 409
  • [9] Familial clustering of Helicobacter pylori infection:: population based study
    Dominici, P
    Bellentani, S
    Di Biase, AR
    Saccoccio, G
    Le Rose, A
    Masutti, F
    Viola, L
    Balli, F
    Tiribelli, C
    Grilli, R
    Fusillo, M
    Grossi, E
    [J]. BRITISH MEDICAL JOURNAL, 1999, 319 (7209) : 537 - 540
  • [10] Helicobacter in the developing world
    Frenck, RW
    Clemens, J
    [J]. MICROBES AND INFECTION, 2003, 5 (08) : 705 - 713